Meta-analysis is a powerful tool for assessing drug safety by combining treatment-related toxicological findings across multiple studies, as clinical trials are typically underpowered for detecting adverse drug effects. However, incomplete reporting of adverse events (AEs) in published clinical studies is frequently encountered, especially if the observed number of AEs is below a pre-specified study-dependent threshold. Ignoring the censored AE information, often found in lower frequency, can significantly bias the estimated incidence rate of AEs. Despite its importance, this prevalent issue in meta-analysis has received little statistical or analytic attention in the literature. To address this challenge, we propose a Bayesian approach to accommodating the censored and possibly rare AEs for meta-analysis of safety data. Through simulation studies, we demonstrate that the proposed method can improve accuracy in point and interval estimation of incidence probabilities, particularly in the presence of censored data. Overall, the proposed method provides a practical solution that can facilitate better-informed decisions regarding drug safety.
Graphical models have witnessed significant growth and usage in spatial data science for modeling data referenced over a massive number of spatial-temporal coordinates. Much of this literature has focused on a single or relatively few spatially dependent outcomes. Recent attention has focused upon addressing modeling and inference for substantially large number of outcomes. While spatial factor models and multivariate basis expansions occupy a prominent place in this domain, this article elucidates a recent approach, graphical Gaussian Processes, that exploits the notion of conditional independence among a very large number of spatial processes to build scalable graphical models for fully model-based Bayesian analysis of multivariate spatial data.